{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260505950494/en/Arrowhead-Pharmaceuticals-Licenses-Clinical-MASH-Program-Targeting-PNPLA3-to-Madrigal-Pharmaceuticals", "message": "News view counter 703111 successfully enlarged"}